Filter
203
Filtered Results: 203
Text search:
vaccine
vial
monitor
Featured
Recommendations
34
New Publications
62
Language
Document type
No document type
91
Guidelines
58
Manuals
21
Studies & Reports
12
Fact sheets
9
Strategic & Response Plan
8
Training Material
2
Resource Platforms
1
Infographics
1
Countries / Regions
India
17
South Africa
10
Uganda
9
Kenya
8
Tanzania
6
Global
5
Philippines
4
Africa
4
Argentina
4
Ethiopia
4
Nepal
3
Rwanda
3
Nigeria
3
Zimbabwe
3
Latin America and the Carribbean
3
Sierra Leone
2
Senegal
2
Bangladesh
2
Zambia
2
Liberia
2
Myanmar / Burma
2
Cameroon
1
Syria
1
Burkina Faso
1
Afghanistan
1
Malawi
1
Guinea
1
Haiti
1
Cambodia
1
Guinea-Bissau
1
Congo, Democratic Republic of
1
West and Central Africa
1
Paraguay
1
United Kingdom
1
Brazil
1
Russia
1
Namibia
1
Yemen
1
Central African Republic
1
Mali
1
Libya
1
Botswana
1
South Sudan
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
83
Clinical Guidelines
35
Women & Child Health
17
Public Health
13
Key Resources
7
Capacity Building
4
Pharmacy & Technologies
2
Toolboxes
COVID-19
45
Pharmacy
17
Rapid Response
15
Polio
7
AMR
6
Ebola & Marburg
5
Caregiver
4
HIV
3
TB
3
NTDs
3
Cholera
2
NCDs
2
Conflict
2
Mental Health
1
Refugee
1
Natural Hazards
1
Planetary Health
1
Zika
1
Interim Guidance, published 11 January 2021.
The cold chain is necessary to prevent damage to vaccines caused by heat exposure. However, improper use of cold chain equipment may cause damage to freeze-sensitive vaccines (i.e. those vaccines containing alum adjuvant or oil-emulsion adjuvant). Studie...
This resource explains how WHO EUL COVID-19 vaccines without vaccine vial monitor or VVM should be handled at the vaccination site, to ensure that safe and potent vaccines are administered.
This document has been updated: 31 August 2021
WHO Vaccine Management Handbook
This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a vaccine and the three clinical trial phases. Part three outlines the nex...
This article is part four in a series of explainers on vaccine development and distribution
Available in different languages
A handbook for district and health facility staff
Accessed December 2017
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
A handbook for district and health facility staff
Accessed Sept, 5 2018
Weekly epidemiological record, Relevé épidémiologique hebdomadaire : Vol.93 (2018) No.13
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
